|
 |
|
|
| |
RegeneRx gets ophthalmic patent in Hong Kong
 |
|
| RegeneRx Biopharmaceuticals has received a patent from the Hong Kong Intellectual Property Department using T4, analogues, isoforms and derivatives to accelerate corneal wound healing and reverse or inhibit eye degeneration |
|
 |
|
|
| |
|
|
| |
|
|
| |
| SemBioSys gets European patent for oleosome emulsions
|
|
| SemBioSys Genetics, a Canadian biotechnology company, said it has been granted European patent entitled Uses of Oil Bodies. The claims of the patent are broadly directed to the production of emulsions comprising oleosomes |
|
|
|
|
| |
|
|
| |
|
|
| |
| Oral type 2 diabetes drug Galvus approved in EU
|
|
| This regulatory approval applies in all 27 countries of the European Union as well as in Norway and Iceland and comes after changes updating the EU label were proposed by Novartis, regarding the administration of Galvus. |
|
|
|
|
| |
|
|
| |
|
|
| More |
